share_log

兆科眼科-B(06622.HK)：用于治疗老花眼的BRIMOCHOL PF及CARBACHOL PF新药临床试验申请获国家药监局批准

Zhaoke Ophthalmology-B (06622.HK): Clinical trial applications for BRIMOCHOL PF and CARBACHOL PF new drugs for the treatment of presbyopia were approved by the National Drug Administration

Gelonghui Finance ·  Jan 24 03:33

On January 24, Gelonghui | Zhaoke Ophthalmology-B (06622.HK) announced that BRIMOCHOL PF and Carbachol PF new drug test applications have recently been approved by the China National Drug Administration (“State Drug Administration”). Based on the “Drug Clinical Trial Approval Notice” approved by the State Drug Administration, the company will conduct tests on presbyopia subjects in China.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment